ArticleJournal of anesthesia2026
Conventional ultrafiltration increases viscoelastic clot firmness during cardiopulmonary bypass: a prospective observational study.
Article in Journal of anesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeUltrafiltration (UF) reduces dilution of all blood components during cardiopulmonary bypass (CPB), but its impact on coagulation performance remains unclear. We examined whether conventional UF mitigates the CPB-induced decline in extrinsic-pathway clot firmness (MCF-EXTEM; reference range 50-72 mm) measured by rotational thromboelastometry (ROTEM), a marker of coagulopathic bleeding risk in cardiac surgery.
methodsIn a prospective observational study, we recruited adult cardiac surgery patients who received UF near the end of CPB (n=39) and included patients with Pre-UF MCF EXTEM ≤50 mm (n=27). Pre-UF versus Post-UF ROTEM parameters, including MCF-EXTEM, fibrin- and platelet-based clot firmness (MCF-FIBTEM and MCF-PLTEM, respectively), were compared (Wilcoxon signed-rank tests). Changes in MCF-EXTEM and their correlation with the volume of filtered free water (UF volume) were analyzed.
resultsUF volume ranging 500-1200 mL increased hematocrit from 21.0% to 25.0% by 4.0% (median, P < 0.001, effect size r = 0.811). As the primary outcome, UF increased MCF-EXTEM from 45.0 mm to 49.0 mm by 4.0 mm (median, 95% confidence interval 2.5‒6.0 mm, P = 0.001, r = 0.755). UF also increased MCF-FIBTEM by 2.0 mm (median, P < 0.001, r = 0.824), but it did not affect MCF-PLTEM (P = 0.060). A moderate positive correlation between UF volume and MCF-EXTEM change was observed (Spearman's ρ = 0.41, P = 0.033).
conclusionsConventional UF during CPB is associated with an attenuation of the CPB‑induced decline in MCF‑EXTEM, and the pattern of changes in FIBTEM and PLTEM is consistent with predominantly fibrin‑related contributions rather than platelet‑related contribution, with an apparent dependence on UF volume.
Indexed as
Identifiers
42789077What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.